Related Experiment Video
Updated: Aug 16, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
Desensitization of beta-adrenergic receptors by pheochromocytoma
Abstract:
Prolonged stimulation of cells by beta-adrenergic receptor agonists may lead to diminished responsiveness of the cells to subsequent activation by catecholamines. This phenomenon has been termed desensitization; the mechanism(s) for desensitization may involve an apparent loss in the number of beta-adrenergic receptors or an alteration in receptor-effector coupling. We have examined the consequences of prolonged stimulation of beta-adrenergic receptors in an interesting rat model harboring pheochromocytoma. New England Deaconess Hospital rats with transplanted pheochromocytomas developed systolic hypertension and plasma norepinephrine concentrations approximately 40-fold greater than controls. beta-Adrenergic receptors were quantitated in several tissues from controls and rats with transplanted pheochromocytoma using the beta-adrenergic receptor antagonist [125I]iodocyanopindolol. Down-regulation of beta 1-receptors was found in heart tissue (22.8 vs. 13.6 fmol/mg protein; P less than 0.001) and adipocytes (29,400 vs. 2,800 sites/cell; P less than 0.001). Also, maximal isoproterenol-stimulated cAMP accumulation in isolated adipocytes was diminished in pheochromocytomic animals (13.1 vs. 4.9 pmol cAMP/10(5) cells/min; P less than 0.05). Interestingly, there was no change in beta-receptors in lung and mesenteric artery, which predominantly contain beta 2-receptors. Furthermore, the competition curves of isoproterenol in the heart membranes from control and pheochromocytomic rats in the absence and presence of guanylylimidodiphosphate indicated uncoupling of the beta-adrenergic receptors in pheochromocytomic animals. Rats with pheochromocytoma secreting large amounts of norepinephrine provide a valuable model system for studying the in vivo development of desensitization.
Insights
Pheochromocytoma in rats causes beta-adrenergic receptor desensitization, leading to reduced receptor numbers and function. This model helps study in vivo beta-adrenergic receptor desensitization mechanisms.
Area of Science:
- Pharmacology
- Endocrinology
- Cardiovascular Research
Background:
- Prolonged beta-adrenergic receptor agonist stimulation can cause cellular desensitization.
- Desensitization may involve receptor number reduction or altered receptor-effector coupling.
Purpose of the Study:
- To investigate beta-adrenergic receptor desensitization in a rat model with pheochromocytoma.
- To analyze the impact of high norepinephrine levels on beta-adrenergic receptors in vivo.
Main Methods:
- Utilized pheochromocytoma-bearing rats with elevated norepinephrine levels.
- Quantified beta-adrenergic receptors using [125I]iodocyanopindolol binding assays.
- Assessed isoproterenol-stimulated cAMP accumulation in isolated adipocytes.
Main Results:
- Observed significant down-regulation of beta 1-adrenergic receptors in heart and adipocytes.
- Found diminished cAMP accumulation in adipocytes from pheochromocytomic rats.
- Detected no change in beta 2-receptors in lung and mesenteric arteries.
- Evidence of beta-adrenergic receptor uncoupling in heart membranes.
Conclusions:
- Pheochromocytoma in rats serves as a valuable model for studying in vivo beta-adrenergic receptor desensitization.
- Elevated norepinephrine levels contribute to beta 1-receptor down-regulation and uncoupling.
- Desensitization involves both receptor number changes and functional alterations.
More Related Videos
Related Concept Videos
Desensitization and Tachyphylaxis
Several...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
Antihypertensive Drugs: Action of β1 Blockers

